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Introduction: Efficiency of obtaining of induced pluripotent stem cells (IPSCs) depends 
critically on the technique used to deliver reprogramming factors (transcription factors such as the 
Sox2, OCT4, Klf1, c-Myc). Currently the most effective systems for the production of IPSCs utilize 
viral vectors. Alphaviruses (gen. Alphavirus, fam. Togaviridae) comprise a genus of RNA-viruses 
that provide high levels of proteins from genes cloned into the viral genome, and the alphaviruses 
do not alter the genome of the host cell. IPSCs obtained using the Alphavirus vectors syngeneic 
with the donor and suitable for medical use. A cDNA of the full-length genome of a model 
alphavirus, the Venezuelan equine encephalitis virus (VEE) was constructed. This cDNA was used to 
rescue the virus from the cDNA copy. Mutations were introduced into the cDNA to make the 
replication noncytopathic. Mutant virus has a stable noncytopathic phenotype, grows to high titers 
and provides synthesis of recombinant proteins. 
Methods: cDNA VEE strain TC-83 was constructed from 9 DNA fragments; each fragment 
was produced de novo, by synthesis from oligonucleotides. Viral RNA was synthesized in vitro and 
transfected into cell cultures (BHK-21, CHO, HEK293). Site-directed mutagenesis and cloning of 
foreign genes into the cDNA was done by PCR-mediated genetic engineering. Virus titers were 
determined using the Reed-Muench method. 
Results: Wild-type VEE (VEEwt) was found to be cytopathic. 100% death of an infected 
monolayer occurred within 48 hours upon infection. Mutations were introduced into the VEE genes 
for non-structural protein nsP2 and the capsid protein. Mutant virus (VEEmut) exerts no 
cytopathicity and accumulates to high titers (>10 FFU/ml). Genes of heterologous proteins (GFP, 
puromycin acetyltransferase, reprogramming factors) were placed under control of the viral 
subgenomic promoter which resulted in the high-level production of these proteins in infected cells. 
Conclusion: The obtained mutant RNA-virus genome is a promising vector for use in novel 
systems for epigenetic reprogramming and production of induced pluripotent stem cells. 
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